I agree that this site is using cookies. You can find further informations here.
X
Duska, L.R.
218  results:
Search for persons X
?
1

Preliminary Clinical Data From Ongoing Phase 2 Study With E..:

Kindler, H. ; Harvey, R.D. ; Duska, L.R....
European Journal of Cancer.  174 (2022)  - p. S31-S32 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Updated Findings and Biomarker Analysis From the Ongoing Ph..:

Papadopoulos, K.P. ; Gutierrez, M. ; Duska, L.R....
European Journal of Cancer.  174 (2022)  - p. S67 , 2022
Link: https://doi.org/10.1016/..
 
?
3

A phase II trial of bevacizumab and rucaparib in recurrent ..:

Jackson, C.G. ; Moore, K.N. ; Cantrell, L....
Gynecologic Oncology.  166 (2022)  1 - p. 44-49 , 2022
Link: https://doi.org/10.1016/..
 
?
4

A phase Ib/II and pharmacokinetic study of EP0057 (formerly..:

Duska, L.R. ; Krasner, C.N. ; O'Malley, D.M....
Gynecologic Oncology.  160 (2021)  3 - p. 688-695 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Outcomes based on treatment regimen in newly diagnosed ovar..:

Washington, C.R. ; Miller, A. ; Moore, K.N....
Gynecologic Oncology.  159 (2020)  - p. 16 , 2020
Link: https://doi.org/10.1016/..
 
?
6

A randomized phase II evaluation of weekly gemcitabine plus..:

Duska, L.R. ; Petroni, G.R. ; Varhegyi, N....
Gynecologic Oncology.  157 (2020)  3 - p. 585-592 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Are minority women less likely to participate in clinical t..:

Staples, J.N. ; Patel, S.N. ; Garcia, C....
Gynecologic Oncology.  159 (2020)  - p. 251 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Tolerability and adverse events experienced by women with o..:

Gillen, J. ; Miller, A. ; Moore, K.N....
Gynecologic Oncology.  159 (2020)  - p. 15-16 , 2020
Link: https://doi.org/10.1016/..
 
?
9

A randomized phase II evaluation of weekly gemcitabine plus..:

Duska, L.R. ; Petroni, G. ; Brown, J....
Gynecologic Oncology.  159 (2020)  - p. 15 , 2020
Link: https://doi.org/10.1016/..
 
?
10

A randomized phase II study of chemoradiation and pembroliz..:

Duska, L.R. ; Scalici, J.M. ; Petroni, G.R..
Gynecologic Oncology.  159 (2020)  - p. 10 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Outcomes of newly diagnosed stage II ovarian, primary perit..:

Washington, C.R. ; Miller, A. ; Moore, K.N....
Gynecologic Oncology.  159 (2020)  - p. 88 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Dkn-01 treated patients with recurrent epithelial endometri..:

Arend, R.C. ; Castro, C.M. ; Matulonis, U.A....
Gynecologic Oncology.  159 (2020)  - p. 5-6 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Preliminary safety, efficacy, and pharmacokinetic/pharmacod..:

Oaknin, A. ; Duska, L.R. ; Sullivan, R.J....
Gynecologic Oncology.  154 (2019)  - p. 17 , 2019
Link: https://doi.org/10.1016/..
 
?
14

A multicenter, open-label, expanded phase 2 study to evalua..:

Rustin, G. ; Vergote, I. ; Micha, J.P....
Gynecologic Oncology.  147 (2017)  2 - p. 276-282 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Intraperitoneal chemotherapy catheter placement using percu..:

Hendricks, N. ; Anderson, C.L. ; Duska, L.R..
Journal of Vascular and Interventional Radiology.  24 (2013)  4 - p. S95-S96 , 2013
Link: https://doi.org/10.1016/..
 
1-15